<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Asinex - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/asi/asi000.html</link>
    <description>Asinex news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 01 Aug 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 01 Aug 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Milestone reached in drug discovery deal</title>
      <description>Asinex has achieved screening results which have met the set criteria of Biovitrum for an undisclosed GPCR target</description>
      <pubDate>Wed, 13 Jul 2005 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi110.html</link>
    </item>
    <item>
      <title>Collaborating over bone and joint drugs</title>
      <description>Galapagos and Asinex have initiated an integrated drug discovery collaboration in bone and joint diseases</description>
      <pubDate>Mon, 16 May 2005 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi109.html</link>
    </item>
    <item>
      <title>Sharing risks in drug discovery</title>
      <description>Biovitrum will access Asinex's highly competitive drug discovery capabilities, including novel libraries of drug-like molecules and expertise in lead development and optimisation</description>
      <pubDate>Mon, 29 Nov 2004 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi108.html</link>
    </item>
    <item>
      <title>Integrated drug discovery project</title>
      <description>Asinex and Recordati announce an integrated drug discovery collaboration in the area of micturition disorders</description>
      <pubDate>Mon, 25 Oct 2004 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi107.html</link>
    </item>
    <item>
      <title>Collaboration for lead generation</title>
      <description>Computational department will create different pharmacophore models and use the results to rank the whole in-house Asinex library</description>
      <pubDate>Fri, 02 Apr 2004 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi106.html</link>
    </item>
    <item>
      <title>Successful bioscreening project</title>
      <description>Proteom, an in silico molecular design company, and Asinex, a company involved in lead generation and optimisation, have announced the completion of a successful bioscreening project</description>
      <pubDate>Thu, 05 Feb 2004 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi105.html</link>
    </item>
    <item>
      <title>Lead optimisation deal extended</title>
      <description>Asinex has agreed a one year prolongation to its multi-FTE deal with Avalon Pharmaceuticals, a next-generation genomics-based company</description>
      <pubDate>Fri, 23 Jan 2004 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi104.html</link>
    </item>
    <item>
      <title>Lead optimisation project with Asahi Kasei</title>
      <description>Asinex is performing optimisation of a hit compound provided by Japanese pharmaceutical company Asahi Kasei at its facilities in Moscow</description>
      <pubDate>Wed, 08 Oct 2003 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi103.html</link>
    </item>
    <item>
      <title>Drug discovery collaboration</title>
      <description>Agreement to carry out screening against a variety of targets and whole cell screens using established library of compounds</description>
      <pubDate>Tue, 02 Sep 2003 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi102.html</link>
    </item>
    <item>
      <title>JandJ contract extended</title>
      <description>Asinex announces a one year extension to collaboration with Johnson and Johnson Pharmaceutical research and development, a division of Janssen Pharmaceutica</description>
      <pubDate>Thu, 24 Jul 2003 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi101.html</link>
    </item>
    <item>
      <title>Multi-FTE deal with Biovitrum</title>
      <description>Provider of lead generation and optimisation services will perform chemical lead optimisation of compounds for biotech company</description>
      <pubDate>Mon, 14 Apr 2003 08:00:00 UT</pubDate>
      <category>Asinex</category>
      <link>http://www.laboratorytalk.com/news/asi/asi100.html</link>
    </item>
  </channel>
</rss>
